Cell Biotech Co., Ltd. (KOSDAQ:049960)

South Korea · Delayed Price · Currency is KRW

14,160

-240 (-1.67%)

At close: Apr 2, 2026

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Finished Product Business			48.60B	44.73B	40.35B	38.31B	39.76B
Finished Product Business Growth			8.66%	10.84%	5.32%	-3.64%	-28.37%
Raw Material Business Division			5.18B	5.80B	6.52B	7.27B	6.20B
Raw Material Business Division Growth			-10.58%	-11.10%	-10.29%	17.29%	-11.90%
Total			53.79B	50.53B	46.87B	45.58B	45.96B
Total Growth			6.46%	7.79%	2.83%	-0.82%	-26.52%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
South Korea			27.85B	27.19B	29.68B	27.76B	26.14B
South Korea Growth			2.42%	-8.38%	6.91%	6.20%	-34.88%
Europe			15.93B	12.98B	9.41B	9.74B	8.78B
Europe Growth			22.75%	37.88%	-3.31%	10.86%	8.59%
Others			10.00B	10.35B	7.78B	8.09B	11.04B
Others Growth			-3.37%	33.06%	-3.77%	-26.75%	-22.90%
Total			53.79B	50.53B	46.87B	45.58B	45.96B
Total Growth			6.46%	7.79%	2.83%	-0.82%	-26.52%

Source: S&P Global Market Intelligence.